Paragon 28, Inc. ( FNA) - Key Metrics
Stock symbol FNA is outdated, potentially delisted? Maybe it is available on other exchange?
FNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.75 | -$0.15 | -$0.03 | -$0.08 |
| 2024Q2 | $0.73 | -$0.17 | -$0.12 | -$0.17 |
| 2024Q1 | $0.74 | -$0.18 | -$0.13 | -$0.21 |
| 2023Q4 | $0.73 | -$0.24 | -$0.20 | -$0.26 |
| 2023Q3 | $0.64 | -$0.10 | -$0.17 | -$0.25 |
FNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -11.31 |
| 2024Q2 | ? | -9.92 |
| 2024Q1 | ? | -16.38 |
| 2023Q4 | ? | -13.16 |
| 2023Q3 | ? | -31.08 |
FNA
Price: $13.09
52 week price:
Earnings Per Share: -0.66 USD
P/E Ratio: -19.82
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 339300
Market Capitalization: 1.1 billion